BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3609917)

  • 1. [Bone marrow histology in myelodysplastic syndromes].
    Frisch B; Bartl R
    Harefuah; 1987 Jan; 112(1):1-3. PubMed ID: 3609917
    [No Abstract]   [Full Text] [Related]  

  • 2. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow histology in myelodysplastic syndromes.
    Frisch B; Bartl R
    Scand J Haematol Suppl; 1986; 45():21-37. PubMed ID: 3457444
    [No Abstract]   [Full Text] [Related]  

  • 4. Topics in bone marrow biopsy pathology: role of marrow topography in myelodysplastic syndromes and evaluation of post-treatment and post-bone marrow transplant biopsies.
    Reddy VV
    Ann Diagn Pathol; 2001 Apr; 5(2):110-20. PubMed ID: 11294998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone marrow biopsy in the study of myelodysplastic syndromes].
    Hernández Nieto L; Brito Barroso ML; Marsá Vilá L; González Brito G; Batista López JN; Ravina M; Rodríguez Martín JM
    Sangre (Barc); 1985; 30(4-C):680-8. PubMed ID: 4089738
    [No Abstract]   [Full Text] [Related]  

  • 6. [Primary myelodysplastic syndromes].
    Brohée D
    Rev Med Brux; 1988 Sep; 9(6):327-33. PubMed ID: 3051250
    [No Abstract]   [Full Text] [Related]  

  • 7. [Myelodysplastic syndromes--diagnostic and therapeutic problems].
    Skotnicki AB; Piatkowska-Jakubas B; Rucińska M; Zduńczyk A
    Przegl Lek; 1988; 45(11):801-11. PubMed ID: 3072594
    [No Abstract]   [Full Text] [Related]  

  • 8. [Delimitation of the concept, nosology and classification of myelodysplastic syndromes].
    Sans-Sabrafen J; Woessner S
    Sangre (Barc); 1985; 30(4-C):633-7. PubMed ID: 4089734
    [No Abstract]   [Full Text] [Related]  

  • 9. [Myelodysplastic syndromes].
    Matsuda A
    Rinsho Ketsueki; 2009 Mar; 50(3):147-53. PubMed ID: 19352080
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of bone marrow study in diagnosis and prognosis of myelodysplastic syndrome.
    Saad ST; Vassallo J; Arruda VA; Lorand-Metze I
    Pathologica; 1994 Feb; 86(1):47-51. PubMed ID: 8072801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Morphology and cytochemistry in the diagnosis of myelodysplastic syndromes].
    Villegas A; Guerra JL; del Potro E; Espinós D
    Sangre (Barc); 1985; 30(4-C):638-50. PubMed ID: 4089735
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bone marrow changes in chronic relapsing polychondritis: potential appearance of myelodysplastic syndromes].
    Diebold J; Rauh G; Löhrs U
    Verh Dtsch Ges Pathol; 1996; 80():331. PubMed ID: 9065046
    [No Abstract]   [Full Text] [Related]  

  • 13. [Contemporary possibilities of prognosis in myelodysplastic syndromes].
    Goździk J; Lewandowski K; Hansz J
    Acta Haematol Pol; 1995; 26(2):129-38. PubMed ID: 7653217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.
    Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
    Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The study and treatment of the myelodysplastic patient.
    Sanz MA; Bennett JM; Vallespí T; Hoelzer D
    Rev Invest Clin; 1994 Apr; Suppl():61-73. PubMed ID: 7886312
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone marrow cell kinetics in primary myelodysplastic syndromes.
    Montecucco C; Riccardi A; Ascari E
    Haematologica; 1987; 72(6 Suppl):132-4. PubMed ID: 3127290
    [No Abstract]   [Full Text] [Related]  

  • 17. Histological and cytogenetic characterization of bone marrow in relation to prognosis and diagnosis of myelodysplastic syndromes.
    Sakuma T; Hayashi Y; Kanomata N; Murayama T; Matsui T; Kajimoto K; Hanioka K; Chihara K; Maeda S
    Pathol Int; 2006 Apr; 56(4):191-9. PubMed ID: 16634964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A preliminary observation of bone marrow angiogenesis in patients with myelodysplastic syndromes].
    Zou WR; Liu T; Meng WT; Yu J; Niu T
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):69-71. PubMed ID: 15702784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Finally progress in the understanding of myelodysplastic syndromes?
    Ganser A
    Wien Klin Wochenschr; 1999 Oct; 111(19):781-3. PubMed ID: 10568009
    [No Abstract]   [Full Text] [Related]  

  • 20. A guide to risk assessment in the primary myelodysplastic syndrome.
    Mufti GJ
    Hematol Oncol Clin North Am; 1992 Jun; 6(3):587-606. PubMed ID: 1613008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.